Loading...
Towards an optimal treatment algorithm for metastatic pancreatic ductal adenocarcinoma (PDA)
Chemotherapy remains the mainstay of treatment for advanced pancreatic ductal adenocarcinoma (pda). Two randomized trials have demonstrated superiority of the combination regimens folfirinox (5-fluorouracil, leucovorin, oxaliplatin, and irinotecan) and gemcitabine plus nab-paclitaxel over gemcitabin...
Na minha lista:
| Udgivet i: | Curr Oncol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Multimed Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5832297/ https://ncbi.nlm.nih.gov/pubmed/29507500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.25.3708 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|